MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
The p53 tumor suppressor integrates upstream signals such as DNA damage and active oncogenes to initiate cell cycle arrest or apoptosis. This response is critical to halting inappropriate growth signals. As such, p53 activity is lost in cancer. In melanoma, however, the p53 gene is intact in a repor...
Saved in:
Main Authors: | Abdullah Alatawi, SoonJye Kho, Michael P. Markey |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Skin Cancer |
Online Access: | http://dx.doi.org/10.1155/2021/3087579 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells
by: Rati Lama, et al.
Published: (2025-01-01) -
Primary liposarcoma of the uterus with MDM2 negative
by: Shufei Wei, et al.
Published: (2024-12-01) -
Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
by: Charmy Twala, et al.
Published: (2025-01-01) -
Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus
by: Yuan Liu, et al.
Published: (2015-01-01) -
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis
by: Vishesh Khanna, et al.
Published: (2025-02-01)